期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CARDIOVASCULAR PATHOLOGY LetPub Score 5.3
50 ratings
Rate
Reputation 6.3 Influence 3.8 Speed 8.8 | ||||||||||||||||||||
期刊簡稱 | CARDIOVASC PATHOL | ||||||||||||||||||||
ISSN | 1054-8807 | ||||||||||||||||||||
E-ISSN | 1879-1336 | ||||||||||||||||||||
h-index | 61 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 8.70%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.cardiovascularpathology.com/ | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CVP | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Elsevier Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 1992 | ||||||||||||||||||||
每年文章數 | 36每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 21.33% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1054-8807%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 6.9 Week(s) | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CARDIOVASCULAR PATHOLOGY] 的評論 | 撰寫評論 |
作者: 邻家佳佳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-23 11:22:44 評論於 Hello, I would like to ask, what is the reason for the journal editor's reply saying that PDF cannot be created?(0) 讚! | 邻家佳佳 |
作者: 璃月玲琳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-06 21:58:22 評論於 Hello, do you need layout fees?(0) 讚! | 璃月玲琳 |
作者: April Ellis 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-02-19 22:13:13 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 95.0 Experience Sharing: Submitted two articles during the epidemic last year, the review process was very quick, 1-1.5 months. One article required multiple revisions based on expert feedback, while the other only needed minor edits. Both articles were in the field of cardiovascular pathology and have been published(0) 讚! | April Ellis |
作者: 上清羡丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-12 20:14:32 評論於 How long will it take to receive the final draft after winning?(0) 讚! | 上清羡丽 |
作者: Vachlan 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-01-23 17:29:33 評論於 This is a relatively good journal; the IF has slowly increased in recent years. I hope that this journal starts attracting high-quality research articles as the readership increases. (0) 讚! | Vachlan |
作者: 迎丝姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-23 15:09:04 評論於 A relatively decent journal, Impact Factor has been steadily rising in recent years; it should be able to attract more good articles(0) 讚! | 迎丝姑娘 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 13:26:24 評論於 On the rise, optimistic about the future, what do you think?(0) 讚! | 凌霄高洁 |
作者: 奉天骞仕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-02-08 13:29:32 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Experience Sharing: I submitted a review article and it was accepted. It was about the molecular mechanisms of congenital heart disease, which was considered quite innovative at the time. After minor revisions, it was accepted. It didn't feel too difficult. However, I later submitted a research article and it was directly rejected(0) 讚! | 奉天骞仕 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-02 14:56:37 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: All three were major revisions, and then all were rejected(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 17:53:02 評論於 Research focus: Cardiovascular(0) 讚! | 凌霄高洁 |
作者: 桃花建茗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-28 22:41:43 評論於 Heavy research focus: Cardiovascular(0) 讚! | 桃花建茗 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us